Form 8-K - Current report:
SEC Accession No. 0001140361-26-006781
Filing Date
2026-02-25
Accepted
2026-02-25 16:11:12
Documents
16
Period of Report
2026-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20066393_8k.htm   iXBRL 8-K 47442
2 EXHIBIT 10.1 ef20066393_ex10-1.htm EX-10.1 91620
3 EXHIBIT 10.2 ef20066393_ex10-2.htm EX-10.2 104962
4 EXHIBIT 99.1 ef20066393_ex99-1.htm EX-99.1 386534
8 image00001.jpg GRAPHIC 4455
  Complete submission text file 0001140361-26-006781.txt   847283

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA adma-20260220.xsd EX-101.SCH 3881
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20260220_lab.xml EX-101.LAB 21967
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20260220_pre.xml EX-101.PRE 16055
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20066393_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 26678648
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)